You just read:

Europe Approves JHL Biotech's Clinical Trial Application for Bevacizumab Biosimilar to Affordably Treat Colorectal, Lung, and Ovarian Cancers

News provided by

JHL Biotech, Inc.

Feb 22, 2018, 08:00 ET